Insilico Medicine

Insilico Medicine uses generative adversarial networks and reinforcement learning to create drug candidates, supported by its own therapeutic pipeline. Unlike Numerion Labs focus on exploring pre-existing chemical space, Insilico emphasizes de-novo generation. It offers both platform access and co-development partnerships, usually under subscription-plus-success-fee terms.